This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Accelrys Announces First Quarter Results

Accelrys, Inc. (NASDAQ:ACCL) today reported financial results for the fiscal quarter ended March 31, 2012. Non-GAAP revenue for the quarter ended March 31, 2012 increased $2.3 million to $41.8 million from $39.5 million for the same quarter of the previous year, or an increase of 6%.

Non-GAAP net income was $4.6 million, or $0.08 per diluted share, for the quarter ended March 31, 2012 compared to non-GAAP net income of $4.7 million, or $0.08 per diluted share, for the same quarter of the previous year. Non-GAAP free cash flow was $7.7 million for the quarter ended March 31, 2012 compared to non-GAAP free cash flow of $9.1 million for the same quarter of the previous year.

The GAAP results for the quarter ended March 31, 2012 were impacted by the business combination accounting associated with the acquisitions of Contur Industry Holding AB and Contur Software AB (collectively, “Contur”) and VelQuest Corporation (“VelQuest”), both in 2011, and the merger with Symyx Technologies in 2010, and by other nonrecurring acquisition-related and restructuring costs. GAAP revenue, GAAP operating loss, GAAP royalty and other income and GAAP net loss for the quarter ended March 31, 2012 were negatively impacted by fair value adjustments to both deferred revenue ($2.4 million) and deferred royalty income ($0.2 million). GAAP operating loss was also negatively impacted by business consolidation, transaction and restructuring costs ($0.6 million), stock-based compensation expense ($1.8 million), and purchased intangible asset amortization ($4.2 million), offset by an adjustment to include acquisition-related cost of revenue related to VelQuest non-GAAP revenue recognized during the quarter ended March 31, 2012 ($0.2 million). GAAP net loss for the same period was negatively impacted by additional purchased intangible asset amortization ($0.4 million), offset by removing the impact ($0.1 million) of the amortization of note receivable discount related to our promissory note receivable from Intermolecular, Inc. (“Intermolecular”).

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs